CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash	$ 50,808	$ 7,815
Prepaid expenses	63,751	0
Total current assets	114,559	7,815
Investments held in Trust Account	21,904,843	21,320,091
Total Assets	22,019,402	21,327,906
Current liabilities:
Promissory notes	1,370,000	1,010,000
Extension loan - related party	70,000	70,000
Working Capital Loan- related party	950,000	700,000
Accounts payable and accrued expenses	211,861	201,819
Total current liabilities	2,601,861	1,981,819
Deferred underwriters' discount	2,415,000	2,415,000
Total Liabilities	5,016,861	4,396,819
Commitments and Contingencies
Ordinary shares subject to possible redemption,1,857,989 and 1,857,989 shares at redemption value of $11.790 and $11.475 per share as of March 31, 2025 and December 31, 2024, respectively	21,904,843	21,320,091
Shareholders' Deficit:
Ordinary shares, $0.0001 par value, 490,000,000 shares authorized, 2,310,750 shares issued and outstanding as of March 31, 2025 and December 31, 2024 (excluding 1,857,989 shares subject to possible redemption)	231	231
Additional paid-in capital	0	0
Accumulated deficit	(4,902,533)	(4,389,235)
Total Shareholders' Deficit	(4,902,302)	(4,389,004)
Total Liabilities, Temporary Equity, and Shareholders' Deficit	$ 22,019,402	$ 21,327,906